NCI's RAS Initiative explores progressive methods for attacking the proteins encoded by mutant sorts of the KRAS gene. A few other KRAS G12C inhibitors are on the heels of sotorasib and therefore are currently getting examined in medical trials. And you will discover most likely far more to come